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Abstract
Cortical atrophy has been documented in both Parkinson’s disease (PD) and healthy aging, but its 
relationship to changes in subcortical white matter is unknown. This was investigated by obtaining 
T1- and diffusion-weighted images from 76 PD and 70 controls at baseline, 18-, and 36-months, 
from which cortical volumes and underlying subcortical white matter axial (AD), radial (RD) 
diffusivities, and fractional anisotropy (FA) were determined. Twelve of 69 cortical subregions had 
significant group differences, and for these underlying subcortical white matter was explored. At 
baseline, higher cortical volumes were significantly correlated with lower underlying subcortical 
white matter AD, RD, and higher FA (Ps ≤0.017) in PD. Longitudinally, higher rates of cortical 
atrophy in PD were associated with increased rates of change in AD RD, and FA values (Ps ≤ 
0.0013) in two subregions explored. The significant gray-white matter associations were not found 
in controls. Thus, unlike healthy aging, cortical atrophy and subcortical white matter changes may 
not be independent events in PD.
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1 INTRODUCTION
Ontogenetically, cortical neurons are born closely to each other in the ventricular zone, and 
migrate along a common pathway to form cortical columns (Rakic, 1988). The final number 
of cortical columns and the number of neurons in each column determines the cortical 
surface area and thickness, respectively (Rakic, 1995). Cortical thickness and surface area 
are thought to be independent genetically, and may reflect separate processes (Winkler et al., 
2010). Cortical volume, however, may be a useful measure to detect overall structural 
changes during aging or disease processes, since it is the combined property of thickness and 
surface area. Indeed, loss of cortical volume has been documented both in healthy aging 
(Abe et al., 2008; Storsve et al., 2014) and Parkinson’s disease (PD) (Lewis et al., 2016), 
although the underlying mechanisms might be different. In healthy aging, dendrite losses 
and/or shrinkage of larger neurons (Terry et al., 1987) may drive the changes in cortical 
volume, since the number of cortical neurons is thought to remain relatively constant 
(Bartzokis et al., 2001; Freeman et al., 2008; Jernigan et al., 2001; Scheibel et al., 1975). In 
PD, cortical cell losses (Jiang et al., 2012; Ribeiro et al., 2013) may contribute to the loss of 
cortical volume.
Post-mortem analysis of Lewy pathology has supported the notion that the progression of 
PD follows a characteristic pattern involving first the brain stem early, and then cortical 
regions as disease advances (Braak et al., 2003a). The recent discovery that Lewy pathology 
can spread across neurons has fueled the notion that neuronal disease may spread in a prion-
like process (Chu and Kordower, 2015). In addition, it has been suggested that long, thin, 
and poorly myelinated neurons (such as cortical projection neurons) are preferentially 
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vulnerable to Lewy pathology (Braak et al., 2006a). Thus, it seems likely that subcortical 
white matter tracts that contain bidirectional axonal projections from cortical neurons 
(Singh, 2006) could be an integral part of the PD process. Thus, we hypothesized that the 
neurodegenerative processes occurring during PD might alter the relationships between 
cortical gray matter and subcortical white matter. The current study utilized cortical gray 
matter volume and subcortical white matter tract diffusion measurements, collected 
longitudinally over 36 months in PD and healthy control subjects, to test this hypothesis.
2 METHODS
2.1 Study subjects
PD (n=76) and control (n=70) subjects having a Mini Mental State Examination score ≥26 
(Dubois et al., 2007; Goetz et al., 2008a) were selected from a longitudinal cohort study 
(Table 1). PD patients were recruited from a tertiary movement disorders clinic, and control 
subjects were recruited from spousal populations and the local community. PD diagnosis 
was confirmed using published criteria (Hughes et al., 1992). All subjects were free of major 
and acute medical issues or neurological disorders except PD. All brain images were 
inspected and deemed free of any major structural abnormalities or motion artifacts. In 
accordance with the Declaration of Helsinki, written informed consent was obtained for all 
subjects. The study protocol was approved by the Penn State Hershey Institutional Review 
Board.
2.2 Clinical information and evaluation
Clinical information and evaluation data were obtained at each visit (baseline, 18-, and 36-
months). Hamilton Depression Rating Scale (Hamilton, 1960) and Montreal Cognitive 
Assessment (Nasreddine et al.) scores were obtained at each visit. In addition, Unified PD 
Rating Scale (UPDRS) motor scores and Hoehn-Yahr stages were assessed for PD subjects 
in the “on-medication” state (Fahn and Elton, 1986; Goetz et al., 2008b). Levodopa-
equivalent daily dose was calculated according to published criteria (Tomlinson et al., 2010).
2.3 MRI data acquisition
All subjects were scanned using a 3.0 Tesla magnetic resonance scanner (Trio, Siemens 
Magnetom, Erlangen, Germany, with an 8-channel phased array head coil) at baseline, 18-, 
and 36-months. A magnetization-prepared rapid acquisition gradient echo sequence was 
used to obtain T1-weighted images with TR/TE = 1540/2.34, FOV = 256 mm x 256 mm, 
matrix = 256 x 256, slice thickness = 1 mm (with no gap), slice number = 176, slice 
selection direction is sagittal. For diffusion tensor imaging, acquisition parameters were as 
follows: TR/TE=8300/82 ms, b value=1000 s/mm2, diffusion gradient directions=42 and 7 
b=0 scans, FOV=256 mm × 256 mm, matrix=128 × 128, slice thickness=2 mm (with no 
gap), and slice number=65, phase encoding direction is axial.
2.4 Structural image processing
T1-weighted brain images were processed automatically using the FreeSurfer (version 5.1.0) 
longitudinal pipeline (Bernal-Rusiel et al., 2013). Briefly, this pipeline creates unbiased 
within-subject templates that then were used to initialize image processing (skull stripping, 
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Talairach transformations, atlas registration, spherical surface maps) for scans at each visit 
(Fischl and Dale, 2000; Reuter and Fischl, 2011). Cortical volumes were computed by 
multiplying cortical thickness and surface area at each cortical surface vertex. Gray matter 
volumes in each cortical region were computed using regional means extracted from cortical 
parcellations (FreeSurfer’s Desikan atlas) (Desikan et al., 2006). Intracranial volume was 
calculated automatically by FreeSurfer using the method described by Buckner et al. 
(Buckner et al., 2004).
2.5 Diffusion tensor image processing
Diffusion image quality control and tensor reconstruction was performed using DTIPrep 
(Neuro Image Research & Analysis Laboratory, University of North Carolina, Chapel Hill, 
NC USA). This software first checks diffusion weighted images for quality by calculating 
the inter-slice and inter-image intra-class correlation, and then corrects for the distortions 
induced by eddy currents and head motion (Liu et al., 2010). Diffusion tensor images 
subsequently were estimated via weighted least squares (Salvador et al., 2005). Additional 
quality control was performed by visually inspecting the images for artifacts and 
directionality. Diffusion tensor images were skull-stripped using brain masks generated from 
the T1 image segmentation step.
Atlas building was performed using a two-stage process in order to ensure that the overall 
final atlas was not biased by subject dropout. The first stage involved creation of within-
subject atlases using images from each subject’s baseline and follow-up images. The second 
stage involved creation of an overall atlas using the within-subject atlases of all subjects. For 
creation of both the within-subject and the overall atlases, we utilized the DTIAtlasBuilder 
program (Neuro Image Research & Analysis Laboratory, University of North Carolina, 
Chapel Hill, NC USA). This software employs a state-of-the-art image registration pipeline. 
To generate atlases, affine registration first is applied using the BRAINSFit module within 
Slicer (Johnson et al., 2007). Second, unbiased diffeomorphic deformations fields are 
computed using the GreedyAtlas module within AtlasWerks (Joshi et al., 2004). Third, a 
refinement step is applied via symmetric diffeomorphic registration with the Slicer DTI-Reg 
module using Advanced Normalization Tools (Avants et al., 2008; Klein et al., 2009). The 
final step of DTIAtlasBuilder concatenates the transforms of the previous steps to compute 
the overall transformation of the original diffusion tensor images into the final average 
diffusion tensor imaging atlas. This allows for mapping between the atlas and the individual 
diffusion tensor images recorded at each visit without the need for resampling.
For the current study, we chose to use axial diffusivity (thought to be more specific to axonal 
degeneration), radial diffusivity (thought to correlate inversely with axonal myelination), and 
fractional anisotropy (FA; thought to reflect overall microstructural integrity) (Aung et al., 
2013; Song et al., 2002; Song et al., 2005). We defined several specific regions of interest on 
the FA map of the average DTI atlas. These regions of interest were chosen specifically for 
their relation to overlying cortical gray matter. “Overall subcortical white matter” was 
defined as a region of interest that was generated by first thresholding the overall final atlas 
image at fractional anisotropy > 0.2 (Supplementary Figure 1). The thresholded mask then 
was edited manually to exclude white matter in the brainstem, cerebellum, thalamus, and 
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other gray matter where fractional anisotropy fell beyond the 0.2 threshold level. This final 
region of interest was used to extract diffusion scalar values of “overall subcortical white 
matter.” We also examined subcortical white matter diffusion scalars in specific subcortical 
regions that were named according to the overlying gray matter. This was performed by co-
registering a standardized white matter parcellation atlas (JHU-MNI-SS-TypeI) with the 
overall final atlas, and then mapping the parcellated white matter regions back to the original 
diffusion tensor images (Oishi et al., 2009).
2.6 Statistical analysis
2.6.1 Group Comparisons—Age and years of education were compared between PD 
and control subjects using two-sample t-tests, whereas gender frequencies were compared 
using Fisher’s Exact Test. Mini Mental State Exam, Montreal Cognitive Assessment, and 
Hamilton Depression scores were compared between groups using Wilcoxon Rank-Sum 
Test. Baseline total and regional cortical gray matter volumes and white matter diffusion 
measurements were compared using one-way analysis of covariance with adjustment for 
age, gender, education, and depression scores, with intracranial volume added as a covariate 
for the gray matter analysis. To limit the probability of false positive findings in our analysis 
of gray matter-subcortical white matter relationships (see below), we restricted our analyses 
to cortical areas that had raw p<0.05 in group comparisons between and control subjects 
(total=12 regions). Rates of annual change in gray matter volumes and white matter 
diffusion were compared between groups using a linear mixed effects model with random 
slopes and intercepts and the same covariates as above, with the additional term of years 
elapsed (since baseline) and the interaction term years elapsed × group.
2.6.2 Gray matter-subcortical white matter associations—The baseline 
relationships between gray matter volume and subcortical white matter diffusion were 
explored using a linear model that included gray matter volume as the dependent variable 
and the following independent variables: subcortical white matter diffusion scalar, 
intracranial volume, age, gender, education, Hamilton depression score, and years since 
diagnosis (as appropriate). To test whether the correlation between gray matter and 
subcortical white matter depended upon group status (PD vs. control), we performed 
interaction analyses by adding the additional independent variable of PD (yes/no) × 
subcortical white matter diffusion scalar.
Longitudinal data were analyzed by linear regression where the slope of white matter 
diffusion across all visits (annual rate per subject) was the dependent variable and the 
independent variable was the slope of gray matter volume across all visits (annual rate per 
subject). Group differences were assessed using the additional term group × annual rate of 
gray matter volume change.
To lessen the likelihood that extreme values and/or non-normally distributed distributions 
might drive the study results, all cross-sectional comparisons and correlations using imaging 
measurements were analyzed using multiple linear regression and p-values generated via 
permutation testing of the model residuals (10,000 iterations) (Anderson and Legendre, 
1999; Freedman and Lane, 1983). Raw p-values are reported due to the step-wise nature of 
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the analysis, however, values that survived correction for multiple comparisons are noted 
(Benjamini and Hochberg, 1995). For the main hypothesis, we focused on total cortical gray 
matter volumes and subcortical diffusion properties, corrected for multiple comparisons 
based on the three diffusion measurements (AD, RD, and FA), and statistical significance 
was defined as p≤0.017. For the explorative analyses, we corrected for multiple comparisons 
based on the 12 regions of interest and three diffusion measurements, with statistical 
significance defined as p≤0.0013. All analyses were completed using R version 3.1.1 (Bates 
et al., 2015; R_Core_Team, 2016).
3 RESULTS
3.1 Demographic and clinical characteristics of study subjects at baseline
Compared to controls, PD subjects were significantly older (p=0.011), but did not have 
significant differences either in gender frequency or education (Table 1). PD subjects, 
however, had lower Mini Mental State Examination (p=0.024) and Montreal Cognitive 
Assessment (p=0.007) scores, and higher depression scores (p<0.0001) than control 
subjects. Clinical characteristics of PD subjects are summarized in Table 1.
3.2 Selection of cortical gray matter regions of interest for correlation analyses
Table 2 summarizes the total gray matter volume data, along with the baseline and annual 
change data for the 12 cortical subregions. As it relates to the primary hypothesis of this 
work, at baseline PD subjects had lower total cortex volume compared to control subjects 
(p=0.006). We then explored gray matter differences of 69 parcellated regions; this revealed 
12 subregions that had significant (p<0.05) group differences. We then focused on the total 
cortical volume-white matter relationship (primary hypothesis), and also explored these 12 
subregions to attempt to understand the relationship between cortical subregional gray 
matter volume and underlying white matter diffusion properties.
Table 3 summarizes the baseline and annual changes of both total subcortical white matter, 
and the 12 regions of interests that were explored. Several significant effects were seen at 
baseline, but none of these differences between PD and control subjects survived correction 
for multiple comparisons either at baseline or longitudinally.
3.3 Correlations of cortical volume and white matter diffusion
At baseline, total cortex volume was correlated negatively with overall subcortical white 
matter axial and radial diffusivity, and positively with overall subcortical white matter 
fractional anisotropy in PD, but not in control subjects (Table 4). None of the associations in 
the 12 studied subregions survived correction for multiple comparisons. The associations 
seemed to be different in PD compared to controls, with only RD surviving multiple 
comparison correction (p=0.011, Figure 1 and Supplemental Table 1).
Longitudinally, annual loss of total cortex volume was not correlated significantly with the 
annual increase in subcortical white matter diffusion measurements (Table 5). The 
exploration of cortical subregions demonstrated that cortical atrophy in the left lateral 
occipital area was significantly associated with increasing axial and radial diffusivities over 
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time, and cortical atrophy in the left postcentral region also was significantly associated with 
increasing fractional anisotropy over time (Table 5, Supplementary Table 2, and Figure 2). 
The associations were not found in controls.
3.4 Sensitivity analysis using matched PD and control samples
In our prior analysis, we factored in age. To address specifically the possibility that the 
correlation differences between PD and control subjects were due to age differences between 
the samples, we performed a sensitivity analysis using 61 PD and 60 control subjects 
matched on age. There was no significant difference in age (p=0.493) or gender (p=0.474) 
between the groups. Baseline overall subcortical white matter radial diffusivity was 
correlated inversely with total cortical volume in PD subjects (p=0.0002), and the 
correlations were absent in controls (p=0.804, interaction p=0.023).
4 DISCUSSION
To our knowledge, the current study is the first to investigate the relationship between gray 
matter atrophy and white matter diffusion properties in PD and healthy controls. The results 
suggest that cortical gray matter atrophy in PD may be related to microstructural changes of 
underlying subcortical white matter, a phenomenon not present in healthy controls. Future 
investigation of the responsible mechanisms is warranted since they may have important 
implications for understanding PD pathology and its progression.
4.1 Gray matter and white matter changes in PD
Gray matter atrophy in PD has been reported by a number of groups (Hwang et al., 2013; 
Ibarretxe-Bilbao et al., 2012; Lewis et al., 2016; Pereira et al., 2014; Ramirez-Ruiz et al., 
2007; Segura et al., 2014; Song et al., 2011; Tinaz et al., 2011; Zhang et al., 2014), and the 
current study confirmed these findings in a longitudinal cohort. On the other hand, past 
research has yielded inconsistent results regarding the extent and nature of white matter 
involvement in PD. Some studies have suggested that PD subjects have altered subcortical 
white matter diffusion properties (Auning et al., 2014; Duncan et al., 2015; Gattellaro et al., 
2009; Gu et al., 2014; Hattori et al., 2012; Huang et al., 2014; Koshimori et al., 2015) 
particularly in advanced-stage, cognitively impaired, and depressed patients (Bohnen and 
Albin, 2011). Conversely, other studies have found none or minimal evidence of altered 
white matter measures in PD (Ji et al., 2015; Rizzo et al., 2008; Tsukamoto et al., 2012; 
Worker et al., 2014). The current study falls on the side of those that report altered white 
matter diffusion properties in several brain regions of non-demented PD subjects. No 
subcortical white matter diffusion differences, however, survived correction for multiple 
comparisons. Similarly, although the rate of cortical gray matter volume loss in most cortical 
regions examined was accelerated significantly in PD compared to control subjects, we 
found no differences in the rates of white matter diffusion change. This may indicate that the 
effects of PD on white matter microstructural integrity are weaker than those leading to gray 
matter atrophy. It also may be that white matter microstructural changes are more difficult to 
capture via diffusion tensor imaging. Larger sample sizes and more sensitive methods for 
capturing white matter properties on imaging might be useful in the future.
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4.2 The gray-white matter associations in PD
Our findings of a gray matter-white matter association in PD are in agreement with those of 
Ham et al. (2015), who reported that cortical atrophy was associated with the distribution of 
white matter hyperintensities in PD. The current study, however, utilized distinct diffusion 
measures (axial and radial diffusivity, and fractional anisotropy) that provide quantitative 
measurements of the microstructural properties of subcortical white matter, as opposed to 
categorical classification of white matter hyperintensities (Ham et al., 2015). In addition, we 
utilized a spatial approach to pair cortical gray matter areas with underlying subcortical 
white matter, and included a control cohort for comparison of correlation strengths. It is 
possible that the observed gray matter-white matter relationships represent separate parallel 
processes throughout PD progression. This is less likely, however, because we included 
years-since-diagnosis” as a covariate in the analyses to account for progression effects. 
Taken together, these findings suggest that degenerative changes in cortical gray matter and 
subcortical white matter are not necessarily independent phenomena in PD.
4.3 Possible biological mechanisms of the gray-white matter associations in PD
Although there are several possible explanations for the observed gray matter-white matter 
correlations in PD, the exact mechanism is unknown. The gray matter-white matter 
associations might be due to the death of the overlying cortical cells resulting in anterograde 
degeneration of axons in the subcortical white matter (Carrera and Tononi, 2014). This 
would be consistent with previous reports suggesting that the number of cortical neurons in 
normal aging remains relatively constant (Freeman et al., 2008; Terry et al., 1987), whereas 
PD subjects undergo cell losses (Braak et al., 2003b; Fukuda et al., 1999; Jiang et al., 2012). 
In addition, microstructural damage to subcortical white matter axons might cause cellular 
changes in the overlying cortical gray matter substrate. This notion is supported by the 
reported cortical atrophy that is associated with subcortical white matter hyperintensities in 
both PD (Ham et al., 2015) and non-PD (Seo et al., 2012) populations. Finally, the extent of 
subcortical white matter myelination may influence cortical neuronal survival in PD. Recent 
studies have indicated that in PD subjects unmyelinated axons in cardiac nerves accumulate 
more α-synuclein aggregates (Orimo et al., 2011), and regions with greater myelination 
during human development are associated with less Lewy deposition (Braak et al., 2006b). 
Thus, it is possible that greater white matter RD (Figures 1 and 2) may represent less axonal 
myelination associated with increased vulnerability of overlying cortical gray matter to α-
synuclein aggregation or Lewy body deposition.
It is important to note that cortical gray matter volume is known to decrease throughout the 
lifespan (Abe et al., 2008; Storsve et al., 2014), and subcortical white matter axial and radial 
diffusivities increase sharply after age 60 (Sexton et al., 2014; Westlye et al., 2010). In 
normal aging, there is a loss of dendrites in the cortex (Dickstein et al.) and subcortical 
white matter fibers (Marner et al., 2003). Consistent with this, the current study found 
overall cortex atrophy and altered subcortical white matter diffusion over time in both PD 
and control subjects. In addition, PD subjects displayed region-specific cortical atrophy in 
the left LOC and POC that were associated with increased diffusion measures over time. The 
finding of differential cortical gray and subcortical white matter associations between PD 
and healthy aging subjects was both unexpected and intriguing. The association between left 
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POC atrophy and increasing fractional anisotropy change (Figure 2) also is unexpected. 
Fractional anisotropy is the synthesized asymmetrical measure of the diffusion that occurs 
along all directions, and it is possible it represents a more complex biological process than 
radial and axial diffusivity. Thus, fractional anisotropy may depend on the stage of disease 
and timing of the measurements. Consistent with this hypothesis, fractional anisotropy 
values have been shown to increase and decrease over time in over the course of disease in 
multiple sclerosis patients (Calabrese et al., 2011; Ontaneda et al., 2014). Future studies, 
especially longitudinal follow-up in patients with different stages and durations of disease, 
are needed to confirm these findings and investigate underlying mechanisms.
4.4 Limitations & conclusions
Although our longitudinal design is a strength, the sample size is still relatively small. In 
designing the study, we tried to balance carefully the potential of both false positive and 
false negative results. To limit the probability of false positive gray-white matter 
associations, we only explored the associations in areas that were found to have lower gray 
matter volumes in PD subjects at baseline. To lower the likelihood of false negatives or 
excluding regions of potential interest, we utilized a criteria of raw p<0.05 for areas to be 
included subsequently in the gray-white matter association analyses. Despite these efforts, it 
still is possible that we excluded some biologically meaningful regions of interest and/or 
introduced false positive regions of interest into the association analyses. It is important to 
point out, however, that 1) several of the reported gray-white matter associations at baseline 
survived correction for multiple comparisons and 2) the results of longitudinal analyses of 
radial and axial diffusivities were consistent with the baseline analysis.
Another limitation of the study is that we define white matter as total cerebral white matter 
or white matter underlying cortical subregions. This approach may lack sensitivity to assess 
the relationship between cortical gray matter and the white matter fibers that connect to it 
since several other fibers (i.e., long-range tracts not necessarily connected to the overlying 
cortex) are included and averaged in the same regions of interest. Future studies with 
tractography-based approaches to characterize white matter diffusion are needed. In this 
study, we utilized time-since-diagnosis as a surrogate for disease duration because time-of-
first-symptom-onset could be vague and less precise than time-of-diagnosis. Further, poor 
white matter microstructure and white matter hyperintensities have been linked with 
cognitive impairment in PD (Agosta et al., 2014; Auning et al., 2014; Baggio et al., 2012; 
Debette and Markus, 2010; Kandiah et al., 2014; Koshimori et al., 2015; Mak et al., 2015; 
Shin et al., 2012; Sunwoo et al., 2014), and our exclusion criteria based on MMSE score 
limited our analysis to non-demented patients. Thus, future studies are warranted to 
determine whether different relationships between gray and white matter occur in subjects 
having PD with dementia. Lastly, we computed the rates of change over 36 months by 
calculating the slope over baseline, 18-, and 36-month visits. It is possible that the rates of 
change, however, could be non-linear as a function of time and further studies with even 
longer follow-up are needed. Nevertheless, the data are consistent with our overall 
conclusion that cortical gray and subcortical white matter are related in PD. Independent 
replication is needed, and may yield important information regarding the underlying 
mechanisms in normal aging and progressive neurodegenerative disease.
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HIGHLIGHTS
• Gray and white matter degeneration have been documented in PD.
• The relationship of gray and white matter in PD is unknown.
• Cortical gray matter atrophy may be related to white matter properties 
in PD.
• These associations are not observed in a healthy aging population.
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Figure 1. Relationships between cortical gray matter volume and underlying subcortical white 
matter diffusion in PD vs. Controls at baseline
Cortex gray matter volumes are shown as a percent of intracranial volume for illustration 
purposes. Figures show regression coefficients for PD and control subjects for the 
correlations between cortex volume and subcortical white matter diffusion measures axial 
diffusion (AD), radial diffusion (RD), and fractional anisotropy (FA). Bolded p values 
represent significant correlations after Bonferroni correction for multiple comparisons 
(p≤0.017). Abbreviations: PD = Parkinson’s disease, WM = white matter.
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Figure 2. Relationship between change in left lateral occipital (LOC) and change in diffusion 
measures axial diffusion (AD) and radial diffusion (RD), and in left posterior occipital cortex 
(POC) and fractional anisotropy (FA) in PD vs. Controls using longitudinal data
Figures show regression coefficients for PD and control subjects for the correlations between 
change in LOC volume and change in diffusion measures axial diffusion (AD) and radial 
diffusion (RD), and POC volume and fractional anisotropy (FA). Bolded p values represent 
significant correlations after Bonferroni correction for multiple comparisons (p≤0.017). PD 
subjects showed decreased AD and RD values with decreasing LOC volume, and decreased 
FA values with decreasing POC volume. The changes in Controls were not significant.
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Table 1
Baseline and follow-up demographic and clinical characteristics of study subjects.
PD Control P-Value
N, Baseline (Female:Male) 76 (29:47) 70 (36:34) 0.134
N, 18 months (Female:Male) 62 (27:35) 60 (31:30) 0.472
N, 36 months (Female:Male) 50 (24:26) 56 (30:26) 0.697
Age (years) 63.3 ± 8.4 59.9 ± 7.7 0.011
Education (years) 15.9 ± 2.7 16.6 ± 2.8 0.135
MMSE 29.1 ± 1.1 29.5 ± 0.9 0.024
MoCA 24.6 ± 3.6 26.1 ± 2.5 0.007
HAM 7.7 ± 4.5 3.8 ± 2.5 <0.0001
UPDRS-III 22.5 ± 14.3 - -
LEDD 557 ± 457 - -
Duration of disease (years) 4.9 ± 5.5 - -
HY Stage 1.8 ± 0.7 - -
Abbreviations – HAM: Hamilton depression rating scale; HY: Hoehn-Yahr; LEDD: levodopa daily equivalent dosage; MMSE: Mini mental state 
exam; MoCA: Montreal Cognitive Assessment; UPDRS: Unified Parkinson’s disease rating scale;
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